Market Introduction
This research report provides insights into the global Cancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines
Market Overview and Dynamics
The North America cancer vaccines market is expected to reach US$ 6,623.6 million by 2027 from US$ 1,875.7 million in 2019. The market is anticipated to grow with a CAGR of 17.5% from 2020 to 2027. Factors driving the market growth include increase in prevalence of cancer worldwide, and initiatives taken by global health research organizations and key players for cancer vaccines.COVID19 has impacted the market heavily due to disruption in supply chain and lockdown conditions. However, the challenges in cancer vaccines industry like higher cost of cancer vaccines restrains the growth of the market.
Key Market Segments
In terms of technology, the recombinant cancer vaccines segment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of end user, the pediatrics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the North America cancer vaccines market included in the report.
Reasons to buy the report
North America Cancer vaccines Market Segmentation
By Technology
North America Cancer Vaccines Market – By Type
North America Cancer Vaccines Market – By Indication
North America Cancer Vaccines Market– By End Use
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,875.7 Million |
| Market Size by 2027 | US$ 6,623.6 Million |
| CAGR (2020 - 2027) | 17.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America Cancer Vaccines Market is valued at US$ 1,875.7 Million in 2019, it is projected to reach US$ 6,623.6 Million by 2027.
As per our report North America Cancer Vaccines Market, the market size is valued at US$ 1,875.7 Million in 2019, projecting it to reach US$ 6,623.6 Million by 2027. This translates to a CAGR of approximately 17.5% during the forecast period.
The North America Cancer Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cancer Vaccines Market report:
The North America Cancer Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cancer Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cancer Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For North America Cancer Vaccines Market
